RNAIII-inhibiting-peptide-loaded polymethylmethacrylate prevents in vivo Staphylococcus aureus biofilm formation

Antimicrob Agents Chemother. 2007 Jul;51(7):2594-6. doi: 10.1128/AAC.00580-06. Epub 2006 Nov 20.

Abstract

Staphylococci, common orthopedic pathogens, form antibiotic-resistant biofilms. Polymethylmethacrylate (PMMA) beads loaded with the quorum-sensing inhibitor RNAIII-inhibiting peptide (RIP) were implanted in rats and shown to prevent methicillin-resistant Staphylococcus aureus infection. RIP release was bimodal, typical of previously-tested antibiotics. These results suggest that RIP-PMMA warrants further evaluation for management of orthopedic infections caused by staphylococci.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Bacterial Agents / pharmacology
  • Biofilms / drug effects*
  • Biofilms / growth & development
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Drug Carriers / chemistry*
  • Male
  • Microspheres
  • Oligopeptides / pharmacology*
  • Oligopeptides / therapeutic use
  • Polymethacrylic Acids / chemistry*
  • Rats
  • Rats, Wistar
  • Staphylococcal Infections / drug therapy
  • Staphylococcal Infections / prevention & control
  • Staphylococcus aureus / drug effects*
  • Staphylococcus aureus / physiology*
  • Vancomycin / pharmacology

Substances

  • Anti-Bacterial Agents
  • Drug Carriers
  • Oligopeptides
  • Polymethacrylic Acids
  • RNAIII inhibiting peptide
  • polymethacrylic acid
  • Vancomycin